GNP Anti Itch Camphor, Menthol .5 g/100g; .5 g/100g Lotion, 212 g
by AMERISOURCEBERGEN DRUG CORPORATION · 212 g in 1 BOTTLE, PUMP (46122-573-10)
NDC 46122-0573-10
🏷️ FDA NDC (as labeled)
46122-573-10
billing pads the product segment with a zero
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
46122-573-10
Product NDC
46122-573
11-digit billing NDC
46122057310
NCPDP billing unit
ML — per mL (volume)
RxCUI
200176
UNII
L7T10EIP3A, 5TJD82A1ET
Application #
M017
SPL Set ID
b4f2d6f7-2287-47d8-e053-2995a90ae335
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2020-11-25
Route
TOPICAL
Dosage form
LOTION
Substance
MENTHOL; CAMPHOR (SYNTHETIC)
GPI-14
90229902104120
GPI class
GNP Anti-Itch
GCN Seq No
023766
GCN
79831
HICL code
002600
Ingredient (HICL)
Menthol/Camphor
HIC1 code
L
Therapeutic class — broad (HIC1)
Skin/Subcutaneous Tissue
HIC2 code
L6
Therapeutic class — intermediate (HIC2)
Irritants
HIC3 code
L6A
Therapeutic class — specific (HIC3)
Irritants/Counter-Irritants
AHFS code
84:92.00.00
AHFS class
Skin And Mucous Membrane Agents, Misc.
FDB label name
ANTI-ITCH 0.5%-0.5% LOTION
FDB brand name
Anti-Itch
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 46122-573-10 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 46122-0573-10. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏭 Manufacturer & labeler
LabelerAMERISOURCEBERGEN DRUG CORPORATION
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code46122
First marketedNov 2020
Product typeHuman Otc Drug
Portfolio37 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name ANTI-ITCH 0.5%-0.5% LOTION Ingredient Menthol/Camphor
🧪 What is this product?
GNP Anti Itch Camphor and Menthol is a topical lotion containing camphor and menthol as active ingredients. This is an over-the-counter monograph product, meaning it is marketed under FDA's established rules for its drug category rather than as an individually approved new drug. Camphor and menthol are commonly used in topical products to produce a cooling or warming sensation and are typically used to temporarily relieve minor itching and skin discomfort when applied to the skin.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Camphor, Menthol?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.022 | — |
| Medicaid paysCMS SDUD · 12 mo | $0.0498 | — |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per mL) — tap or hover for the price & month
▲ Up 12% over the last 20 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Rugby Anti-Itch .5 g/100g; .5 g/100g 00536-1268-12 | RUGBY | 212 g | $0.022 | — | Availability likely | — |
| GNP Anti Itch .5 g/100g; .5 g/100gthis 46122-0573-10 | AMERISOURCEBERGEN | 212 g | $0.022 | — | Availability likely | — |
| Leader Anti-Itch .5 g/100g; .5 g/100g 70000-0546-01 | LEADER/Cardinal | 212 g | $0.022 | — | Availability likely | — |
| Walgreen Anti Itch .5 g/100g; .5 g/100g 00363-4262-75 | Walgreens | 212 g | — | — | FDA listed | — |
| Discount Drug Mart Anti-Itch .5 g/100g; .5 g/100g 53943-0262-75 | Discount | 212 g | — | — | FDA listed | — |
| CVS Anti-Itch .5 g/100g; .5 g/100g 69842-0626-75 | CVS | 212 g | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2020
On the market since
Nov 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🗺️ Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 46122-0573-10, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
105
Units reimbursed last 4 qtrs
23.3K
Gross reimbursed last 4 qtrs
$1.2K
Avg / prescription
$11.05
Avg / unit
$0.0498
Latest quarter Q1 2026
13Rx
Medicaid pays / mL
$0.0498
gross reimbursed
vs
NADAC / mL
$0.0221
acquisition cost
=
Spread
+$0.0277
+125% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 0 Rx Managed care · 105 Rx
State Medicaid map
Units reimbursed · per 100k residents
128378
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 46122-0573-10 You're viewing this | 212 g in 1 BOTTLE, PUMP (46122-573-10) | 2020-11-25 | Active |
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses temporary relieves pain and itching due to: insect bites minor burns sunburn minor skin irritations minor cuts scrapes rashes due to poison ivy, poison oak, and poison sumac
⏱️ Dosage and Administration ▾
Directions to open, squeeze cap tightly and turn pump counter-clockwise adults and children 2 years and older: apply to affected area not more than 3 to 4 times daily children under 2 years: ask a doctor
⚠️ Warnings ▾
Warning For external use only Ask doctor before use on chicken pox on measles when using this product do not get into eyes Stop Use and ask doctor if condition worsens symptoms last more than 7 days or clear up and occur again within a few days Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away.
📦 Storage and Handling ▾
Other information store at 20 °C to 25 °C (68 °F to 77 °F)
🧪 Active Ingredient ▾
Active Ingredients Camphor 0.5%............................................................................................................................ External analgesic Menthol 0.5%.............................................................................................................................. External analgesic
🧪 Inactive Ingredients ▾
Inactive ingredients carbomer 940, cetyl alcohol, DMDM hydantoin, fragrance, glyceryl stearate, isopropyl myristate, PEG-40 stearate, PEG-100 stearate, purified water, sodium hydroxide, stearic acid, white petrolatum.
🎯 Purpose ▾
Purpose Anti - itch
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.